In addition to PKCβ, it has been reported that abnormal activation of PKCα which is one of cPKCs exacerbates DN by enhancing transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF) signaling pathways in podocytes51–54. Here, PRKCB is linked to liver dysplastic nodule.